Antithrombotic strategies after cryptogenic stroke: a systematic review, pairwise, and network meta-analysis of randomized controlled trials

Back

ESC Premium Access

Antithrombotic strategies after cryptogenic stroke: a systematic review, pairwise, and network meta-analysis of randomized controlled trials

Session: Novel anticoagulants and indications

Topic: Anticoagulants

Speaker: Doctor M. Abouzid (Poznan, PL)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Mohamed Abouzid

Poznan University of Medical Sciences, Poznan (Poland)

1 follower

7 more presentations in this session

Factor XI activity in ST-segment elevation myocardial infarction

Speaker: Doctor M. Spagnolo (Catania, IT)

Direct oral anticoagulants or warfarin in patients with left ventricular thrombus: a meta-analysis of randomized clinical trials

Speaker: Doctor M. Maqsood (Houston, US)

Direct Oral Anticoagulants versus Vitamin K Antagonists for the management of left ventricular thrombus after myocardial infarction: A meta-analysis

Speaker: Doctor C. Gogos (Thessaloniki, GR)

Edoxaban for stroke prevention in routine practice patients with atrial fibrillation with and without atherosclerotic disease: a post-hoc sub-study of ETNA-AF-Europe

Speaker: Doctor T. de Vries (Amsterdam, NL)

Unfractionated heparin or low molecular weight heparin in patients with acute pulmonary embolism: a meta-analysis of randomized controlled trials

Speaker: Doctor M. Maqsood (Houston, US)

Access the full session

Novel anticoagulants and indications

Speakers: Doctor M. Abouzid, Doctor M. Spagnolo, Doctor M. Maqsood, Doctor C. Gogos, Doctor T. de Vries...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources